A subset of cancer-associated fibroblasts (FAP+/CAF-S1) mediates immunosuppression in breast cancers, but its heterogeneity and its impact on immunotherapy response remain unknown...
Read More »
Researchers from Medical University of Innsbruck introduce quanTIseq, a method to quantify the fractions of ten immune cell types from bulk RNA-sequencing data. quanTIseq was extensively validated in blood and tumor samples using simulated, flow...
Read More »
Date: Thursday, May 23, 2019Time: 10AM PDT | 1PM EDTSpeaker: Dr. Ankita DasCheckpoint inhibitors have produced durable responses, even cure, in patients who have failed all therapies. This phenomenon is unprecedented in cancer treatment...
Read More »
A computational imaging-based signature of immune-cell infiltration in and around a tumor could predict patients’ responses to treatment with anti-PD1/PDL1 immunotherapies, according to data from a study presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held ...
Read More »
Firma – OncoImmunity AS Sted – Oslo Cancer Cluster Incubator, Ullernchausséen 64, Oslo 0379 Oslo Frist – 31.01.2016 Varighet – Fast Sektor – Privat Stillingstittel – Software development manager Bransje – Helse og omsorg / IT – programvare Stillingsfunksjon IT ...
Read More »
The tumour microenvironment is the non-cancerous cells present in and around a tumour, including mainly immune cells, but also fibroblasts and cells that comprise supporting blood vessels. These non-cancerous components of the tumour may play an important role in cancer ...
Read More »
RNA-Seq Blog Transcriptome Research & Industry News
